Using an alkaline phosphatase-based genetic screening method, we identified a number of proteins that are potentially located on the outer surface of Group B streptococcus (Streptococcus agalactiae). In an enzyme-linked immunosorbent assay, antisera raised against two of the proteins, the streptococcal yutD homologue and a subunit of an ABC transporter, recognised clinically important serotypes of Group B streptococcus. In a neonatal rat model, purified IgG from the sera conferred significant levels of protection against a lethal challenge infection. The proteins identified show potential as protein subunit candidates for vaccines against Group B streptococcal disease in neonates.
Introduction
Group B streptococcus (GBS, Streptococcus agalactiae) is the causal agent of a broad range of human diseases. Of these, the most prominent are septicemia, pneumonia and meningitis of neonates. The major component of the cell surface is a polysaccharide capsule of which there are at least 10 antigenically distinct types. Although antibodies against capsule are protective, the polysaccharide capsule itself is associated with a number of di⁄culties for use as a vaccine candidate. As well as a need for the inclusion of at least ¢ve serotypes, it is poorly immunogenic. To elicit a good immune response, each polysaccharide would need to be independently conjugated to a carrier protein. However, whole GBS cells contain a complement of proteins embedded throughout this capsule. The identi¢cation of these proteins may reveal candidates for vaccines against GBS infection. Many proteins have been identi¢ed using direct methods. These include the tandem repeat proteins, alpha-C protein [1] and Rib protein [2] , the beta-C protein [3] , X proteins [4] , glutamine synthetase [5] , K-enolase [6] , Hsp70 [7] and Sip [8] . A recent proteomic screen of the outer surface proteins also revealed the presence of several other proteins [9] , including non-phosphorylating glyceral-dehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, ornithine carbamoyltransferase, glucose-6-phosphate isomerase and purine nucleoside phosphatase.
An alternative method to identify outer surface proteins is to interrogate the DNA sequence. Using a bioinformatic approach, the sequence of the genome is examined for signal sequences [10] . Generation of the genome sequence and analysis of hypothetical hits is time-consuming and labour-intensive. Further, it requires knowledge of the appropriate sequences responsible for protein export in that particular organism. Many of the proteins named above would not have been identi¢ed as being present on the outer surface of an organism based on such an in silico approach. Consequently as an alternative, we undertook a biological screen of the genomic DNA of GBS using the alkaline phosphatase reporter system [11] .
Molecular fusion of DNA to an appropriate reporter gene has been used extensively in studies on cellular location of proteins [12] , topology of proteins [13] and to screen for unknown exported proteins in several di¡erent bacteria. These include Streptococcus pneumoniae [14] , Staphylococcus aureus [15] , Helicobacter pylori [16] , Mycobacterium tuberculosis [17] and Actinobacillus actinomycetemcomitans [18, 19] . Using a homologous system, a method for screening for signal sequences in GBS has also been described [20] . This study only identi¢ed a limited number of proteins, and also admitted that there was little di¡er-ence between the results obtained from the homologous system and a heterologous one where the proteins were expressed in Escherichia coli. Consequently to identify further outer surface proteins of GBS that may be vaccine candidates, we undertook a study to search for genes with signals capable of exporting proteins using an E. coli system. Of the proteins identi¢ed in this study, two were selected for further analysis. Their location as outer surface proteins was con¢rmed prior to the demonstration of in vivo e⁄cacy as vaccine candidates.
Materials and methods

Bacterial strains
S. agalactiae serotypes and strains used were Type III (strain M732 (8)), Type I a/c (RF76, an isolated pathogenic strain which, due to patient consent restrictions, we are unable to release), Type I b/c (strain H36b, ATCC), Type II (strain 18RS21, NCTC), Type IV (strain R80405, ATCC), Type I a/c (strain A909, ATCC) and Type V (Prague strain supplied by PHLS, Collingdale). All strains used were maintained on Columbia horse blood agar plates (Oxoid, Basingstoke, UK). Liquid cultures for sample preparation were grown overnight in Todd^Hewitt broth (Oxoid) at 37 ‡C. Prior to harvesting, cells were checked for serogroup speci¢city by latex agglutination test (Oxoid).
Construction of GBS DNA-phoA libraries
A 20 min partial restriction of 250 Wg of GBS genomic DNA (strain M732) was performed using 18 units of Sau3AI (NEB, Hertfordshire, UK). The resulting fragments were separated over a 10^40% sucrose gradient which was spun for 24 h at 85 000Ug in an SW40 swing-out rotor (Beckman Ultracentrifuge, Beckman Coulter, Buckinghamshire, UK). Following analysis by agarose gel electrophoresis, fractions containing fragments of less than 1 kb in size were pooled, dialysed and the DNA precipitated prior to ligation into the vectors. Three vectors were used based on pFW-phoA [21] , which features a leaderless E. coli phoA gene downstream of a multi-cloning site. The basic vector, pFW-phoA1, di¡ers from the others in the addition of one (pFW-phoA2) or two (pFW-phoA3) base pairs in the multi-cloning site, resulting in fusions in the three possible reading frames. The vectors were restricted with BamHI and the GBS DNA fragments were ligated into them. The products of each ligation reaction were separately transformed into the E. coli phoA-host strain, DH5K.
Analysis of clones exhibiting alkaline phosphatase activity
The products of the transformation reactions were plated onto L-agar containing 100 Wg ml 31 spectinomycin and 40 Wg ml 31 of the chromogenic substrate, XP (5-bromo-4-chloro-3-indoyl-phosphate; Roche Diagnostics, Sussex, UK). Individual positive (blue) colonies were picked and re-streaked on XP-containing plates. Finally, to con¢rm the phenotype, plasmid DNA from the positive cultures was isolated and retransformed into DH5K cells. The transformants were once again assayed for activity. Plasmid DNA from the positive cultures was sequenced using an ABI 310 automated sequencer (ABI, Warrington, UK) running an ABI big-dye terminator mix chemistry (ABI). The GBS sequence present in the clones was compared to DNA sequences deposited in publicly accessible databases for putative identi¢cation. Unless speci¢cally stated, all sequence accession numbers used in this text can direct the reader to the sequence through the trEMBL supplement to the SWISS-PROT database (http://www.expasy. org/sprot/).
Generation of full-length sequence
From the list of sequences generated, two genes were chosen for further analysis. The sequence obtained from the screen was used to design DNA primers. These were used to sequence genomic GBS DNA in an 'outwards' direction (i.e. towards the 5P and 3P ends of the gene). The termini of the genes were determined at the 5P end by the presence of a ribosome binding site [22] positioned appropriately in relation to a 'start' codon, and at the 3P end by repeated sequencing of putative termination codons.
Cloning, expression and puri¢cation of proteins
Primers were designed to amplify the full-length genes, and included restriction endonuclease recognition sites to facilitate subsequent cloning steps. Due to the high AT content of the GBS sequences (and GBS genomic DNA in general), the primers designed were unusually long to allow a raised annealing temperature to be used. The sequences of the primer pairs used to amplify Pho3-1 were 5P-CCATATGCGAAAAGAAGTGACACC-3P and 5P-GCGGCCGCTATTATCCTTTCTTATTTTTCTTAC-G-3P, and for Pho2-2, 5P-CCTCTAGAAATAATTTTG-TTTAACTTTAAGAAGGAGATATATACATATGGG-CCAAGAACCTATCATCG-3P and 5P-GCGGCCGCT-ATTACAAATCTTCCTTCTTCAAAG-3P.
The restriction enzyme recognition sites (underlined) were designed to allow excision and cloning of Pho3-1 by NdeI and NotI at the 5P and 3P ends, respectively, whilst the enzyme used to digest the 5P end of the Pho2-2 gene was XbaI, with NotI being used at the 3P end. The use of the XbaI site as a cloning site necessitated the inclusion of a ribosome binding site (which is removed from the expression vector following digestion with XbaI and NotI). Following polymerase chain reaction (PCR) of the GBS DNA with the appropriate primer pairs, ampli¢ed fragments were cloned into an appropriate commercially viable expression system. Gene identity was veri¢ed by sequencing.
Pho3-1 was expressed in a soluble form when induced with a low concentration (100 WM) of isopropyl thiogalactose (IPTG) and grown at reduced temperatures (20 ‡C). Following sonication, protein was puri¢ed by two rounds of subtractive ion exchange chromatography. Protein was equilibrated to pH 7.2, then passed ¢rst through a Q Sepharose Hi-Trap column (Amersham Pharmacia Biotech, Buckinghamshire, UK) and then pooled £ow-through containing Pho3-1 was passed through an SP Sepharose HiTrap column. The £ow-through was collected, proteinconcentrated using a vivaspin centrifugal ultra¢ltration device (Sartorius) and identity of the puri¢ed protein was con¢rmed by amino acid analysis (Alta Bioscience, University of Birmingham). Purity was estimated by analysis of a Coomassie blue-stained SDS^PAGE (polyacrylamide gel electrophoresis) gel.
Pho2-2 accumulated in insoluble inclusion bodies in culture. Inclusion bodies were puri¢ed by pelleting, and then dissolved in 10 mM Tris pH 7.2, 8 M urea. Following renaturation by dilution with 10 mM Tris pH 8.5, 5 mM EDTA, 1 mM oxidised glutathione, 5 mM reduced glutathione, the protein was loaded onto a Q Sepharose column. The protein was eluted with 10 mM Tris pH 8.5, 1 M NaCl. Following dilution to reduce the NaCl concentration, the protein was concentrated and identity and purity con¢rmed as for Pho3-1.
Sera and analysis
Fractions containing recombinant protein were used to immunise New Zealand White rabbits (AbCam, Cambridge, UK). Rabbits were immunised with 100^150 Wg of protein plus Freund's complete adjuvant for the initial immunisation and for the three subsequent booster injections, each at 28-day intervals, Freund's incomplete adjuvant and protein. Antisera were tested for speci¢city by probing Western blots of recombinant protein and GBS outer surface proteins prepared from strain M732 (prepared and veri¢ed as being free from intracellular contamination as previously described, [9] ). Proteins were analysed on a 12% criterion SDS polyacrylamide gel (BioRad, Hertfordshire, UK) prior to blotting onto 0.2 mm nitrocellulose membrane (Bio-Rad). Blots were blocked with 3% bovine serum albumin (BSA) prior to probing with a 1:5000 dilution of the test or pre-immune sera. Blots were decorated with goat anti-rabbit alkaline phosphatase-conjugated secondary antibody (Sigma, Dorset, UK), and the blot was developed with Western blue stabilised substrate (Promega, Southampton, UK).
Whole cell enzyme-linked immunosorbent assay (ELISA)
The sera directed against the recombinant proteins were used to challenge GBS in whole-cell ELISAs. Six strains of GBS, representing the major clinical serotypes, were used. The cells were grown to mid-exponential phase, harvested, washed with phosphate-bu¡ered saline (PBS) and used to coat ELISA plates (Nunc Immunosorb, Life Technologies, Paisley, UK). The supernatant from the wells was carefully aspirated following overnight coating at 4 ‡C, and assayed for the presence of the intracellular marker, aldolase [23] . All subsequent incubations were performed at 37 ‡C for 1 h unless otherwise stated. After blocking with 3% BSA, the plates were probed with 50 Wl of 10-fold serial dilutions of pre-and post-immune sera. Antibody was decorated with alkaline phosphatase-conjugated antirabbit IgG (Sigma) at a dilution of 1:5000 with PBS, which was in turn detected with p-nitrophenyl phosphate (Sigma). Plates were incubated at 37 ‡C for 30 min, then read at 405 nm.
Animal protection
The antibodies were tested for ability to protect against GBS disease in a passive neonatal rat model. IgG directed against the recombinant proteins was puri¢ed by Protein A a⁄nity chromatography (Protein A Sepharose, Amersham Pharmacia Biotech), concentrated by ammonium Sequences were subjected to BLAST searches, and the results are reported in terms of closest similarities, and the percentage similarity and identity the query protein has to the database hit, and the length of the sequence over which the similarity/identity was seen. sulphate precipitation, resuspended and dialysed against PBS. The concentration of puri¢ed IgG in the samples was between 25 and 35 mg ml 31 . Previous experiments had demonstrated no protective activity of pre-immune sera, so negative controls were supplied by PBS-injected pups. Positive control serum was raised against whole GBS (A909 strain) (anti-whole cell) using a protocol designed to raise a response against the carbohydrate capsule [24] .
50 Wl IgG containing solution was injected via the intraperitoneal route into 24-h old pups, with 30 pups being used in each group. In all cases, pups from ¢rst-time mothers were used in order to eliminate experimental complications due to the presence of anti-GBS antisera in the mothers [25] . The pups were removed from their mothers and the litters were randomised prior to treatment with antisera to avoid bias in survival due to di¡ering levels of maternal care. The pups were rested for between 5 and 7 h prior to challenge to allow for entry of the IgG into the circulation. We demonstrated (data not shown) that this was a su⁄cient amount of time in order to allow maximum concentration of antibody to be present in the circulation. Pups were challenged subcutaneously with 5U10 4 cfu Type I a/c (A909) GBS (determined empirically to represent an LD 80À100 dose, data not shown) and observed for 64 h. The experiments were repeated independently nine times for the PBS control group, ¢ve times for treatment with anti-whole cell, seven times for treatment with anti-Pho2-2 IgG, and three times for treatment with anti-Pho3-1 IgG.
Pups were scored when an end point had been reached. This was empirically realised and de¢ned as two of the following symptoms being observed: excessive pallor, generalised erythema, subcutaneous haemorrhaging, redness at site of bacterial injection, reduced body temperature, or increased muscle tone. Once an end point was reached, the pups were humanely killed.
The animals were housed and maintained in accordance with the Code of Practice for the Housing and Care of Animals used in Scienti¢c Procedures issued by the UK Home O⁄ce. The experiments were carried out under the authority of a Project Licence granted under the Animals (Scienti¢c Procedures) Act 1986.
Results and discussion
Alkaline phosphatase screen
Three GBS^phoA gene fusion libraries were created by the insertion of Sau3AI-digested GBS chromosomal DNA fragments into the plasmids pFW-phoA1, pFW-phoA2 and pFW-phoA3. Approximately 30 000 transformants were screened, and 83 which possessed alkaline phosphatase activity were shown to be stable and contain GBS DNA inserts. Of these, 42 were unique. 32 of these sequences were analysed using bioinformatic tools. Table 1 shows the results of this analysis.
Based on the analysis and other studies (data not shown), two of the proteins were selected for further analysis^Pho2-2 and Pho3-1.
3.2. Cloning of full-length genes for Pho2-2 and Pho3-1, and expression of recombinant proteins
The full-length sequences for the Pho2-2 and Pho3-1 genes have been assigned as GenBank accession numbers CAC09093 and CAC09097, respectively. Neither of these genes have been previously described in GBS. In silico translation of these sequences enabled a search of the trEMBL database to be performed, and in agreement with the results of the initial screen, the highest homologies to Pho2-2 (for proteins with con¢rmed identity) are against the ATPase subunit of ABC transport systems such as that from the L-carnitine transporter in Listeria monocytogenes (AAF91342), the glycine betaine/carnitine/ choline transporter from S. aureus (BAB96237) or the proline/glycine betaine transport system of Clostridium acetobutylicum (Q97F91). Walker A and B motifs can be identi¢ed in this protein, as can an ATP active binding domain, con¢rming the identity of the protein.
Pho3-1 is one of a growing number of hypothetical proteins identi¢ed from genome sequencing projects. These include Bacillus subtilis (O32127), Streptococcus pyogenes (AAL98118) and S. pneumoniae (AAK99479). Pho3-1 shows at least 50% identity and 68% similarity to all of these proteins. There is no signi¢cant homology of these proteins to any with an assigned function.
Both proteins expressed to high levels when the genes were cloned into the pET29a expression vector. The yield of puri¢ed protein from 250 ml of starting culture for Pho3-1 was approximately 2.75 mg, and for Pho2-2, approximately 9.75 mg. In both cases it was estimated (by Coomassie blue staining of SDS^PAGE gels, data not shown) that the protein samples were over 90% pure. Amino acid analysis of the puri¢ed samples matched the predicted composition of the proteins, con¢rming identity and intactness.
Sera directed against Pho3-1 and Pho2-2 react against whole GBS
The individual puri¢ed proteins were used to immunise New Zealand White rabbits. Fig. 1 shows Western blots using the sera, reacted against blots of both the recombinant protein and a preparation of GBS outer surface proteins. As can be seen, the size of both recombinant protein and the reacting band in the GBS outer surface protein preparation are essentially the same, indicating that the recombinant proteins against which the antibodies were raised were full-length. Additional, lower molecular-mass bands are visible reacting to proteins in the OSP preps, which could represent breakdown products. Additionally, a higher-weight molecular mass protein in the recombinant protein preparation is recognised by the antiPho3-1 antibody, possibly due to read-through of the transcript, past the stop codon.
Using the same sera, whole GBS cells were screened in an ELISA to give additional con¢rmation that these antigens were located on the surface of the cell and that they were present in representative strains from the clinically important GBS serotypes. Further con¢rmation of the presence of the two genes across di¡erent serotypes was obtained by BLAST searching the recently elucidated genomes for GBS Type III and Type V using the Pho3-1 and Pho2-2 amino acid sequences. This showed the identity levels were 84% and 99%, respectively, in both strains. To con¢rm that the cells had maintained their integrity on the ELISA plate, the supernatant (following coating) was carefully aspirated and assayed for the presence of the intracellular marker, aldolase [23] . Results (not shown) demonstrated that less than 3% of the cells lysed during the process.
Results of the ELISA with primary anti-sera at a dilution of 1:1000 are shown in Fig. 2 . For both of the antisera investigated, the post-immune sera reacted to a much greater level than the pre-immune sera. Furthermore, the sera reacted with all of the serotypes tested, indicating the presence of the antigen on the surface of all the major serotypes. The comparatively low levels of reactivity against the Type III (M732) strain has been seen for other sera raised against outer surface proteins [9] , and probably re£ects masking of the protein by the thick carbohydrate capsule [26] , which in turn is in£uenced by growth conditions [27] .
Anti-Pho2-2 and anti-Pho3-1 antibodies protect against GBS infection
As it was demonstrated that the Pho2-2 and Pho3-1 antigens were located on the surface of GBS, we postulated that the proteins might be candidates for vaccines against the disease. To test this, a passive immunisation experiment was performed using puri¢ed anti-Pho2-2 and Pho3-1 IgG, to test for protection against infection. The results are shown in Fig. 3 .
The anti-whole-cell immunoglobulin was able to provide s 90% protection against infection, as would have been anticipated^whilst 80% of those animals which had been treated with PBS succumbed to the infection. Using Dunnett's test for analysis, the odds of survival in both the anti-Pho2-2 and anti-Pho3-1 groups were signi¢-cantly greater than the odds of survival in the PBS control group with 95% con¢dence, though not as great as that observed for the anti-whole-cell-treated animals.
The identi¢cation of outer surface proteins is a process by which novel candidates for vaccines against bacterial diseases may be discovered. This is particularly the case where it is known that the main immunogenic determinant of the bacteria is not a protein, and is serotype-speci¢c as is the case with GBS. A protective response against the GBS capsular carbohydrate does not provide cross-type protection [28] . Vaccination with a protein present in a range of serotypes would overcome this issue.
Outer surface proteins may be identi¢ed by one of several methods. We have previously described work undertaken to examine the major proteins on the cell surface by direct sequencing of enzymatically extracted proteins [9] . Whilst this proteomic method is powerful and resulted in the identi¢cation of protective outer surface proteins, only the most abundant 20 or so proteins were identi¢ed. An alternative method is to examine the genome for proteins with known signal sequences for protein export, or for membrane anchorage. This methodology has also been used to identify potential targets in Neisseria meningitidis [29] . However, only proteins which conform to the current cannon of signal sequences will be identi¢ed. Further, the genome sequence needs to be available and that of GBS has only recently been released [30, 31] . Consequently, we have employed a functional method, relying on identi¢ca-tion of genetic fusions of GBS export signals with a leaderless PhoA molecule. Fig. 1 . Western blot analysis of puri¢ed recombinant Pho2-2 and Pho3-1 (Recomb.) and GBS outer surface proteins (OSP) probed with pre-immune (PI), anti-Pho3-1 and anti-Pho2-2 antisera (T). Proteins were analysed by SDS^PAGE, blotted to nitrocellulose and probed with a 1:5000 dilution of pre-immune-phase sera or antisera. Blots were decorated with anti-rabbit alkaline phosphatase-conjugate secondary antibody and were developed with Western blue substrate (Promega). Mw, molecular mass. Fig. 2 . Sera directed against Group B streptococcal Pho2-2 and Pho3-1 recognises GBS in a whole-cell ELISA. Cells of six GBS serotypes, Type I a/c (RF76a), Type I b/c (H36b), Type II (18RS21, Type III (M732), Type IV (R80405) and Type V (Prague strain) were used to coat ELISA plates, which were subsequently challenged with rabbit preimmune sera, or antisera raised against Pho2-2 or Pho3-1. The reacting antibody was decorated with secondary (goat-anti-rabbit, alkaline phosphatase-conjugated) antibody, and the reaction developed with PNPP and read at 405 nm.
All the evidence presented here indicates that both the Pho2-2 and Pho3-1 molecules are resident on the outer surface of the GBS bacteria. They confer an export phenotype to the leaderless PhoA, antisera raised against the recombinant proteins recognise an appropriately sized protein on a Western blot of outer surface proteins, the antisera recognise whole cells and, most convincingly, IgG directed against the proteins protects against GBS infection in an in vivo model. In neither case were these proteins identi¢ed by proteomic examination of the outer surface protein pro¢le. It is unlikely that either would they have been identi¢ed by reverse vaccinology. Bioinformatic analysis (PIX analysis) demonstrates that Pho3-1 does not possess a classical signal motif, whilst Pho2-2 has a possible, but ambiguous signal. In addition, the lack of N-terminal signal-motif or the Gram-positive anchor motif LPXTG for either of the proteins raises the question of how they are attached to the cell surface, or the mechanism of export. As such, Pho2-2 and Pho3-1 join a growing list of such proteins [32] .
Bioinformatic analysis of Pho3-1 o¡ers little indication as to its function. Homology searches using this sequence reveals that it is a member of a protein family which has been identi¢ed in several Gram-positive bacterial species from genomic sequencing projects. The homologous proteins have been given various nomenclatures, including yutD (B. subtilis), SPy1534 (S. pyogenes), SP0767 (S. pneumoniae), and ybiC (Lactobacillus lactis). There are no proteins with signi¢cant homology to Pho3-1 to which a biological function has been assigned. Identi¢cation of this protein as being present on the outer surface of the bacteria should aid in studies designed to elucidate the function.
The Pho2-2 protein is of particular interest. The bioinformatic search identi¢es the protein as the Walker-motifcontaining ATP binding protein of an ABC cassette. The topology of these multi-unit proteins identi¢es the ATPbinding domains as being intracellular [33] . It is therefore surprising to have identi¢ed this subunit as being present on the outer surface of the bacteria. Whilst this was a surprising result it is not without precedent. The presence of a Walker-motif-containing portion of an ABC protein on the surface of S. aureus has been reported previously [34] , and polyclonal antisera raised against the protein proved e⁄cacious as an immunotherapeutic agent. Together with the data presented here, this suggests that the ATPase is, indeed on the outer surface of the cell. It has been hypothesised for other ABC proteins that the ATPase spans the membrane, with portions being available to the external environment [35^39]. However, other comprehensive studies have demonstrated that the ATPase is not accessible to the external environment [40] . It is possible therefore that when on the outside of the cell, the protein is not part of the ABC multi-subunit protein, and is acting in a di¡erent, independent role. The presence of proteins on the bacterial cell surface which have alternate intracellular roles has been widely reported [5^7,9] and suggests that these proteins may have more than one role. This has been demonstrated, for example, for intracellular enzymes which also display extracellular binding functions [6, 41] . It is tempting to speculate therefore that Pho2-2 is performing a role other than that of an ABC protein-associated ATPase on the surface of GBS.
Using the PhoA fusion technology, we have successfully identi¢ed two novel vaccine candidates, Pho2-2 and Pho3-1 for GBS. Antisera directed against both these candidates provide signi¢cant protection in an in vivo model. It is thus possible that the proteins themselves may be e⁄cacious in preventing the disease, if administered as an active protein subunit vaccine either singly or in combination. As the antisera recognise examples from the clinically important serotypes, this protection should be more broad-ranging than that o¡ered by capsular carbohydrate. Fig. 3 . Anti-Pho2-2 and anti-Pho3-1 IgG o¡ers statistically signi¢cant protection against infection with a lethal challenge of GBS in a neonatal animal model. Puri¢ed IgG raised against whole GBS cells (WC), Pho2-2 or Pho3-1 proteins were used to passively immunise neonatal rat pups. After a rest period the pups were challenged with a lethal dose of GBS. The monitored animals were scored as non-survivors when a prede¢ned end point had been reached. Means and standard deviation of nine (PBS), ¢ve (WC), seven (Pho2-2) and three (Pho3-1) independent experiments are shown.
